What were the main drivers of Stryker's revenue growth in Q1 2005?

Stryker's revenue growth of 16% was driven by a combination of factors including increased unit volume and favorable product mix (12%), higher selling prices (2%), positive foreign currency exchange rate movements (1%), and contributions from acquisitions (1%). Both the Orthopaedic Implants and MedSurg Equipment segments experienced strong shipment growth.

How did the eTrauma acquisition impact Stryker's financials in Q1 2005?

Stryker acquired eTrauma.com Corp. on February 23, 2005, for approximately $50 million. While it expanded Stryker's product offerings in endoscopic and medical video imaging, its results did not materially impact the company's reported operating results for the first quarter of 2005.

What is Stryker's outlook for the remainder of 2005?

Stryker provided an optimistic outlook for 2005, expecting diluted net earnings per share to approximate $1.75. The company anticipates net sales to increase in the range of 15% to 16%, driven by strong performance in its key segments, favorable foreign currency movements, and higher revenue from Physical Therapy Services.

Are there any significant legal or regulatory matters that investors should be aware of?

Stryker disclosed ongoing cooperation with the Department of Justice regarding investigations into billing and coding practices of its subsidiary Physiotherapy Associates, Inc., and into consulting contracts with orthopedic surgeons. While the company is cooperating fully, it does not anticipate material losses beyond amounts already provided for in its financial statements.

SYK 10-Q Quarterly Report Q1 FY2005 — Revenue, Net Income, EPS

Summary

Stryker Corporation reported strong financial performance for the first quarter ended March 31, 2005. Net sales increased by 16% to $1.2 billion, driven by robust growth in both its Orthopaedic Implants and MedSurg Equipment segments. Net earnings saw a significant rise of 27% to $173.1 million, translating to a 26% increase in basic earnings per share to $0.43. This growth was fueled by increased unit volumes, higher selling prices, favorable foreign currency exchange movements, and strategic acquisitions. The company demonstrated improved operational efficiency, with a decrease in selling, general, and administrative expenses as a percentage of sales, and a reduction in days sales outstanding and days sales in inventory. Stryker also maintained a strong liquidity position, with substantial cash on hand and significant available borrowing capacity, positioning it well for future investments in growth and potential acquisitions. The company provided an optimistic outlook for 2005, projecting diluted earnings per share of approximately $1.75 and anticipating a net sales increase of 15% to 16%.

Key Highlights

1Net sales increased 16% year-over-year to $1.20 billion, indicating strong market demand.
2Net earnings grew 27% to $173.1 million, with diluted EPS rising to $0.42.
3Orthopaedic Implants and MedSurg Equipment segments both showed significant sales growth, with MedSurg Equipment sales up 24%.
4The company acquired eTrauma.com Corp. for approximately $50 million to expand its endoscopic products and medical video imaging equipment offerings.
5Operating income increased by 27% to $246.2 million, reflecting effective cost management.
6Stryker maintained a healthy liquidity position with $244.7 million in cash and equivalents and $824.3 million in available borrowing capacity.
7The company reaffirmed its full-year 2005 outlook, expecting diluted EPS of approximately $1.75 and net sales growth of 15-16%.

STRYKER CORP Quarterly Report for Q1 Ended Mar 31, 2005

Summary

Key Highlights

Frequently Asked Questions